FDAnews Device Daily Bulletin

nContact Gets IDE to Research Closed-Chest Convergent Ablation Procedure

April 20, 2010
A A
nContact Surgical, Inc Monday announced it has received the first Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration to evaluate the safety and efficacy of a combined surgical and catheter procedure (the convergent procedure) to treat patients with longstanding persistent atrial fibrillation.
Yahoo!